Dynavax Technologies
DVAX
#4890
Rank
โ‚น166.18 B
Marketcap
โ‚น1,415
Share price
1.75%
Change (1 day)
31.57%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: โ‚น166.18 Billion

As of January 2026 Dynavax Technologies has a market cap of โ‚น166.18 Billion. This makes Dynavax Technologies the world's 4890th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น166.18 B2.5%
2025โ‚น162.12 B10.59%
2024โ‚น146.60 B-2.55%
2023โ‚น150.43 B33.92%
2022โ‚น112.33 B-10.58%
2021โ‚น125.61 B250.3%
2020โ‚น35.86 B4.82%
2019โ‚น34.21 B-14.94%
2018โ‚น40.21 B-44.41%
2017โ‚น72.35 B599.62%
2016โ‚น10.34 B-83.25%
2015โ‚น61.72 B119.59%
2014โ‚น28.11 B-11.66%
2013โ‚น31.82 B11.56%
2012โ‚น28.52 B28.08%
2011โ‚น22.27 B34.34%
2010โ‚น16.57 B363.54%
2009โ‚น3.57 B122.26%
2008โ‚น1.60 B-79.82%
2007โ‚น7.97 B-50.61%
2006โ‚น16.14 B260.03%
2005โ‚น4.48 B-45.32%
2004โ‚น8.20 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Dynavax Technologies was reported to be:

โ‚น166.18 Billion
by Nasdaq info icon info icon
โ‚น166.18 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
โ‚น13.04 B-92.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น2.457 T 1,379.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น24.616 T 14,712.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น13.730 T 8,162.06%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น26.202 T 15,667.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚น9.191 T 5,431.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น12.968 T 7,703.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.395 T 1,943.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚น15.821 T 9,420.68%๐Ÿ‡บ๐Ÿ‡ธ USA